Network meta-analysis of iGlarLixi, a fixed-ratio combination GLP-1 RA and basal insulin, versus insulin premix

AUTHORS: Sayre T., Shah R., Thomas J., Murray E., Brulle-Wohlhueter C., Shaunik A., Perfetti R.
CONFERENCE: IDF Congress 2017
DATE: December 4-8, 2017.


To better understand the clinical efficacy of iGlarLixi compared with insulin intensification options, especially premix insulins, in patients with T2D inadequately controlled on BI